SCHEMBL6672055

SCHEMBL6672055

COc1ccc(CC(CC(=O)c2ccc(F)cc2)C(=O)O)cc1.Cc1ccc(C(=O)CC(Cc2ccccc2)C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
ATM Q13315 1/20 0.50
KMO O15229 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
PPARG P37231 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 1/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
PPARA Q07869 2/20 0.46
LDHA P00338 1/20 0.46
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6675156 0.94 NPC1 (0.53) KMT2AKMONPC1RAB9ALMNA
SCHEMBL3110072 0.92 LDHA (0.54) KMT2AKMONPC1RAB9APPARG
SCHEMBL6672057 0.91 NPC1 (0.46) KMT2AMEN1ATMNPC1RAB9A
SCHEMBL6662270 0.89 KMT2A (0.48) KMT2AMEN1ATMKMONPC1
SCHEMBL16284887 0.88 NPC1 (0.60) KMT2AKMONPC1RAB9AMAPT
SCHEMBL6672877 0.88 NPC1 (0.60) KMT2AKMONPC1RAB9AMAPT
SCHEMBL3101828 0.88 NPC1 (0.60) KMT2AKMONPC1RAB9AMAPT
SCHEMBL16284888 0.88 NPC1 (0.60) KMT2AKMONPC1RAB9AMAPT
SCHEMBL6670996 0.88 ALDH1A1 (0.51) KMT2AMEN1KMORAB9ALMNA
SCHEMBL6675163 0.85 NPC1 (0.51) KMT2AMEN1NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458412-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GmbH (DE) 2004-09-22 EP disclosed
WO-2003055523-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GMBH (DE) 2003-07-10 WO disclosed